GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
This NIH U01 grant establishes the GREGoRi Technology Integration Center to set standards and best practices for applying new molecular methods in rare disease diagnosis, including building a bench…
- Deadline
- Oct 30, 2026
- Posted
- Jun 18, 2026
- Award amount
- Up to $2,250,000
- Focus areas
- Health
Don’t miss this deadline
We’ll email you before Oct 30, 2026 so you have time to apply.
In plain English
This NIH U01 grant establishes the GREGoRi Technology Integration Center to set standards and best practices for applying new molecular methods in rare disease diagnosis, including building a benchmarking dataset; clinical trials are optional. It is a research grant for universities, research institutions, and similar eligible organizations. Foreign organizations and foreign components are not eligible to apply. The award maximum is about $2.25 million. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Who can apply
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this grant
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants funding Health — soonest deadline first.
Alcohol Health Services Research (R01 Clinical Trial Optional)
National Institutes of Health · Up to $500K · Due in 17 days
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
National Institutes of Health · Up to $500K · Due in 17 days
Metastasis Research Network (U54 Clinical Trial Not Allowed)
National Institutes of Health · Up to $1.3M · Due Sep 25, 2026
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Up to $1.5M · Due Sep 30, 2026
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
National Institutes of Health · Up to $2.2M · Due Sep 30, 2026
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
National Institutes of Health · Up to $500K · Due Oct 1, 2026
Also listed under National Institutes of Health and Health Grants.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.